Pemetrexed disodium hemipentahydrate

Pemetrexed Disodium Hemipentahydrate is a chemotherapy drug mainly used to treat malignant pleural mesothelioma and non-squamous non-small cell lung cancer (NSCLC). It is often used in combination with cisplatin or other platinum-based chemotherapy drugs, and also as maintenance therapy or second-line treatment in NSCLC cases. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Alimta and Pemetrexed sodium hydrate (2:4:5). Its PubChem CID is 135564527.

CAS No 357166-30-4
Molecular Formula C40H48N10Na4O17
Molecular Weight 1032.8 g/mol
Synonyms tetrasodium;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate;pentahydrate

Frequently Asked Questions